Abstract:Background: Androgen receptor (AR) plays important role in the development, progression, and metastasis of prostate cancer (PCa). Caffeic acid phenethyl ester (CAPE) is the main component of honey bee propolis. We determined if CAPE affects the signaling and stability of AR in PCa cells. Methods: Effects of CAPE on AR transcriptional activity and localization were determined by reporter gene assay and immunofluorescent microscopy. Western blotting, fluorescent polarization, computer simulation, and animal experiment were performed to investigate the molecular mechanism how CAPE reduces the stability of AR. Results: CAPE treatment dose-dependently suppressed the transcriptional activity of AR as well as the protein levels of AR and its target gene PSA. Cyclohexamide treatment revealed that androgen stabilized AR protein, but AR stability was diminished by CAPE. Fluorescence microscopy demonstrated that androgen promoted the nucleus translocation of AR in PCa cells, while treatment with CAPE reduced protein level of AR in both nucleus and cytoplasm. CAPE treatment suppressed the phosphorylation of Ser81 and Ser213 on AR, which regulates the stability of AR. CDK1 and AKT are the kinases phosphorylating Ser81 and Ser213 on AR, respectively. CAPE treatment significantly reduced the protein level and activity of CDK1 and AKT in PCa cells. Overexpression of CDK1 or AKT rescued the AR protein level under CAPE treatment. Conclusions: Our results suggested that CAPE treatment reduced AR stability and AR transcriptional activity in PCa cells, implying the possibility of using CAPE as a treatment for advanced PCa.

Structural Basis for the Inhibition of AKR1B10 by Caffeic Acid Phenethyl Ester (CAPE).

In Vitro CAPE Inhibitory Activity Towards Human AKR1C3 and the Molecular Basis.

Caffeic acid phenethyl ester ( CAPE ) revisited : Covalent modulation of XPO 1 / CRM 1 activities and implication for its mechanism of action

Discovery of CAPE derivatives as dual EGFR and CSK inhibitors with anticancer activity in a murine model of hepatocellular carcinoma

Caffeic acid phenethyl ester (CAPE) revisited: Covalent modulation of XPO1/CRM1 activities and implication for its mechanism of action

Carpesium Abrotanoides (L.) Root As a Potential Source of Natural Anticancer Compounds: Targeting Glucose Metabolism and PKM2/HIF-1α Axis of Breast Cancer Cells.

Naturally occurring caffeic acid phenethyl ester from chestnut honey-based propolis and virtual screening towards DYRK1A

Caffeic acid phenethyl ester suppresses androgen receptor signaling and stability via inhibition of phosphorylation on Ser81 and Ser213

Design and Synthesis of Polyhydroxy Steroids As Selective Inhibitors Against AKR1B10 and Molecular Docking.

Structure-Activity Relationship for Anti-Haemolysis and Cytotoxicity Against HL-60 Cells of Caffeic Acid Phenethyl Ester Derivatives

Caffeic Acid Phenethyl Ester Inhibits the Proliferation of HEp2 Cells by Regulating Stat3/Plk1 Pathway and Inducing S Phase Arrest.

Bioactivity and Chemical Synthesis of Caffeic Acid Phenethyl Ester and Its Derivatives

Caffeic Acid Phenethyl Ester: A Potential Therapeutic Cancer Agent?

Inhibitor Selectivity Between Aldo – Keto Reductase Superfamily Members AKR 1 B 10 and AKR 1 B 1 : Role of Trp 112 ( Trp 111 )

Synthesis and biological evaluation of steroidal derivatives as selective inhibitors of AKR1B10

Screening, Synthesis, Crystal Structure, and Molecular Basis of 6-Amino-4-phenyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitriles As Novel AKR1C3 Inhibitors.

Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment

Caffeic Acid Phenethyl Ester and Its Benzoyl Derivatives: Synthesis and X-ray Structural Analysis

The Pluripotent Activities of Caffeic Acid Phenethyl Ester

Free Radical Scavenging and Antioxidative Activities of Caffeic Acid Phenethyl Ester (CAPE) and Its Related Compounds in Solution and Membranes: A Structure–activity Insight

Caffeic Acid phenethyl ester is a potential therapeutic agent for oral cancer